The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exosomes secreted from mesenchymal NSCLC cells to promote invasiveness and metastatic capability of recipient cells through UCHL1.
 
Yoshihisa Shimada
No Relationships to Disclose
 
Tetsuya Okano
No Relationships to Disclose
 
Paul Yenerall
No Relationships to Disclose
 
Kenneth Huffman
No Relationships to Disclose
 
Brenda Timmons
No Relationships to Disclose
 
Boning Gao
No Relationships to Disclose
 
Dhruba Deb
No Relationships to Disclose
 
Norihiko Ikeda
No Relationships to Disclose
 
John D. Minna
Stock and Other Ownership Interests - ABION; Allergan; Bluebird Bio; EW; HCN Welltower; InNexus; Omega Healthcare Investors; Regeneron; Seagen; VEEV Veena Systems
Research Funding - Pfizer (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - MiNA Therapeutics Licensing of technology; National Cancer Institute (NCI) USA royalties for licensing of human cancer cell lines.; University of Texas Southwestern Medical Center royalties for licensing of human cancer cell lines.; University of Texas Southwestern Medical Center Royalties for licensing of human cancer cell lines. (Inst)